Clinical applications of hallucinogens: A review.
Albert Garcia-Romeu, Brennan Kersgaard, Peter H. Addy
Exp Clin Psychopharmacol August 1, 2016 DOI: 10.1037/pha0000084 via PubMed Central
Summary
AI-generated from the abstractHallucinogens are grouped into classes—psychedelics, entactogens, dissociatives, and others—based on how they work in the brain and their chemical structure. While these classes have different primary mechanisms, they all can temporarily and profoundly change consciousness, affecting body sensations, perception, thinking, and emotions. These effects likely explain their recreational use, but a growing body of evidence suggests therapeutic applications beyond abuse potential. This review covers data on several hallucinogen classes, focusing on psychedelics, entactogens, and dissociatives, where clinical utility is best documented. It traces historical insights, compares classes from molecular to behavioral levels, and presents up-to-date clinical research with implications for therapeutic value.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Anxiety MDMA PTSD |
| Keywords | Psychedelics: psilocybin Hallucinogens Hallucinogen-assisted therapy Mental health: depression |
| Citations | 198 |
| Key finding | A growing body of evidence indicates that hallucinogens may have therapeutic applications beyond their potential for abuse, particularly for psychedelics, entactogens, and dissociatives. |
Abstract
Hallucinogens fall into several different classes, as broadly defined by pharmacological mechanism of action, and chemical structure. These include psychedelics, entactogens, dissociatives, and other atypical hallucinogens. Although these classes do not share a common primary mechanism of action, they do exhibit important similarities in their ability to occasion temporary but profound alterations of consciousness, involving acute changes in somatic, perceptual, cognitive, and affective processes. Such effects likely contribute to their recreational use. However, a growing body of evidence indicates that these drugs may have therapeutic applications beyond their potential for abuse. This review will present data on several classes of hallucinogens with a particular focus on psychedelics, entactogens, and dissociatives, for which clinical utility has been most extensively documented. Information on each class is presented in turn, tracing relevant historical insights, highlighting similarities and differences between the classes from the molecular to the behavioral level, and presenting the most up-to-date information on clinically oriented research with these substances, with important ramifications for their potential therapeutic value. (PsycINFO Database Record